The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD)
locus contains one of the last major unidentified autosomal-dominant genes underlying these …

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are age-related
neurodegenerative disorders with shared genetic etiologies and overlapping clinical and …

MATR3 is an RNA- and DNA-binding protein that interacts with TDP-43, a disease protein
linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Using exome …

Background Tofersen is an antisense oligonucleotide that mediates the degradation of
superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis. Intrathecal …

MR-guided focused ultrasound (MRgFUS) is an emerging technology that can accurately
and transiently permeabilize the blood-brain barrier (BBB) for targeted drug delivery to the …

The G 4 C 2 repeat expansion in C9orf72 is the most common known cause of amyotrophic
lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). We tested the …

Amyotrophic lateral sclerosis (ALS) is a conformational disease in which misfolding and
aggregation of proteins such as SOD1 (familial ALS) and TDP-43 (sporadic ALS) are central …

Bulbar motor deterioration due to amyotrophic lateral sclerosis (ALS) leads to the eventual
impairment of speech and swallowing functions. Despite these devastating consequences, no …

Objective: We aimed to determine the effectiveness of IV immunoglobulin (IVIG) in the
treatment of patients with myasthenia gravis (MG) and worsening weakness in a randomized, …

Background Glutamate excitotoxicity might contribute to the pathophysiology of amyotrophic
lateral sclerosis. In animal models, decreased excitatory aminoacid transporter 2 (EAAT2) …